Erratum: "Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer". Rolof G.P. Gijtenbeek, Vincent van der Noort, Joachim G.J.V. Aerts, Jeske A. Staal-van den Brekel, Egbert F. Smit, Frans H. Krouwels, Frank A. Wilschut, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Joost D.J. Janssen, Martijn Goosens, Paul M. van den Berg, A. Joop de Langen, Jos A. Stigt, Ben E.E.M. van den Borne, Harry J.M. Groen, Wouter H. van Geffen and Anthonie J. van der Wekken. ERJ Open Res 2022; 8: 00239-2022.
{"title":"Erratum: \"Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) <i>versus</i> intercalated TKI with chemotherapy for <i>EGFR</i>-mutated nonsmall cell lung cancer\". Rolof G.P. Gijtenbeek, Vincent van der Noort, Joachim G.J.V. Aerts, Jeske A. Staal-van den Brekel, Egbert F. Smit, Frans H. Krouwels, Frank A. Wilschut, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Joost D.J. Janssen, Martijn Goosens, Paul M. van den Berg, A. Joop de Langen, Jos A. Stigt, Ben E.E.M. van den Borne, Harry J.M. Groen, Wouter H. van Geffen and Anthonie J. van der Wekken. <i>ERJ Open Res</i> 2022; 8: 00239-2022.","authors":"","doi":"10.1183/23120541.50239-2022","DOIUrl":null,"url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1183/23120541.00239-2022.].</p>","PeriodicalId":11739,"journal":{"name":"ERJ Open Research","volume":"10 1","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10851952/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ERJ Open Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/23120541.50239-2022","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
[This corrects the article DOI: 10.1183/23120541.00239-2022.].
勘误："表皮生长因子受体突变非小细胞肺癌一线酪氨酸激酶抑制剂（TKI）与间充式 TKI 加化疗的随机对照试验"。Rolof G.P. Gijtenbeek、Vincent van der Noort、Joachim G.J.V. Aerts、Jeske A. Staal-van den Brekel、Egbert F. Smit、Frans H. Krouwels、Frank A. Wilschut、T. Jeroen N. Hiltermann、Wim Timens、Ed Schuuring、Joost D．J. Janssen、Martijn Goosens、Paul M. van den Berg、A. Joop de Langen、Jos A. Stigt、Ben E.E.M. van den Borne、Harry J.M. Groen、Wouter H. van Geffen 和 Anthonie J. van der Wekken。ERJ Open Res 2022; 8: 00239-2022。
[This corrects the article DOI: 10.1183/23120541.00239-2022.].
期刊介绍：
ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
